The synthesis of N-substituted benzimidazole (H+-K+)-ATPase or proton-pump inhibitors is described. These compounds were prepared to function as prodrugs of the parent NH compound and evaluated for their ability to inhibit gastric (H+-K+)-ATPase and gastric acid secretion. The prodrugs reported rely on either in vivo esterase hydrolysis for liberation of the parent compound (type I and type 11) or require an acid environment for release of the ...